Blood Gas Analyzer Market worth $3.38 billion by 2030

 The report Blood Gas Analyzer Market by Product (Consumables, Services), Type of Testing (PoC, Conventional), Sample (Arterial, Venous, Capillary Blood), Application (Respiratory, Emergency Care Management), End User (Hospitals, Clinics) — Global Forecast to 2030”, is valued at an estimated USD 2.70 billion in 2025 and is projected to reach USD 3.38 billion by 2030 at a CAGR of 4.6% during the forecast period.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963

The blood gas analyzer market is set to experience robust growth driven by several key factors. Firstly, advances in technology such as multi-parameter analysis, automated calibration, and real-time data integration have improved the accuracy and efficiency of blood gas monitoring, enabling better clinical decision-making. Furthermore, the growing adoption of point-of-care testing in critical care, emergency, and respiratory care settings, expanding healthcare infrastructure, and increasing healthcare spending in developing regions are further propelling market growth.

In 2024, the arterial blood segment held the largest share of the blood gas analyzer market by sample type segment.

The blood gas analyzer market is segmented based on sample type into arterial, venous, and capillary blood. In 2024, the arterial blood segment held the largest share of the market, as it provides the most accurate and reliable measurement of oxygen, carbon dioxide, and pH levels, which are critical for patient assessment. Arterial sampling is widely preferred in hospitals and critical care settings for routine monitoring and clinical decision-making, driving higher demand.

In 2024, the critical care management segment held the largest share of the blood gas analyzer market by application segment.

The blood gas analyzer market is segmented by application into critical care management, respiratory care, emergency care management, and other applications. In 2024, critical care management held the largest share, as patients in intensive care units require frequent monitoring of blood gas levels to manage critical and unstable health conditions. The high frequency of testing in ICUs, where multiple measurements may be performed per patient daily, drives substantial demand for blood gas analyzers in this application area.

North America has the largest regional share in the blood gas analyzer market.

The blood gas analyzer market is divided into five key regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America held the largest share, primarily driven by its well-established diagnostics ecosystem, with the US as the primary contributor. This regional dominance is supported by strong healthcare infrastructure, a high prevalence of chronic and acute diseases, and significant investments in advanced diagnostic technologies and innovations.

The major players operating in this market are Danaher Corporation (US), Werfen S.A. (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Nova Biomedical (US), Medica Corporation (US), Techno Medica Co., Ltd. (Japan), IDEXX Laboratories, Inc. (US), EDAN Instruments, Inc. (China), and Guangzhou Wondfo Biotech Co., Ltd. (China).

Comments

Popular posts from this blog

Urology Devices Industry worth $48.6 billion by 2028

Adhesion Barrier Industry worth $0.9 billion by 2028, with a CAGR of 7.4%

Healthcare Simulation Market worth $4.6 billion by 2028